Serum 25-hydroxyvitamin D, calcium, phosphorus, and electrocardiographic QT interval duration: Findings from NHANES III and ARIC

Journal of Clinical Endocrinology and Metabolism

Volumn 96, Issue 6, 2011, Pages 1873-1882

  Zhang, Yiyi ^a   Post, Wendy S ^a   Dalal, Darshan ^a   Bansal, Sandeep ^a   Blasco Colmenares, Elena ^a   Jan De Beur, Suzanne ^a   Alonso, Alvaro ^a   Soliman, Elsayed Z ^a   Whitsel, Eric A ^a   Brugada, Ramón ^a   Tomaselli, Gordon F ^a   Guallar, Eliseo ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; CALCIUM; PHOSPHORUS;

ADULT; ARTICLE; CALCIUM BLOOD LEVEL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ELECTROCARDIOGRAPHY; FEMALE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; QT INTERVAL; UNITED STATES; VITAMIN BLOOD LEVEL;

CALCIUM; CROSS-SECTIONAL STUDIES; ELECTROCARDIOGRAPHY; FEMALE; HEART CONDUCTION SYSTEM; HUMANS; MALE; MIDDLE AGED; PHOSPHORUS; VITAMIN D;

EID: 79956299591     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2010-2969     Document Type: Article

References (42)

1. Chonchol M, Dale R, Schrier RW, Estacio R 2009 Serum phosphorus and cardiovascular mortality in type 2 diabetes. Am J Med 122:380-386
2. Tonelli M, Curhan G, Pfeffer M, Sacks F, Thadhani R, Melamed ML, Wiebe N, Muntner P 2009 Relation between alkaline phosphatase, serum phosphate, and all-cause or cardiovascular mortality. Circulation 120:1784-1792
3. Tonelli M, Sacks F, Pfeffer M, Gao Z, Curhan G 2005 Relation between serum phosphate level and cardiovascular event rate in people with coronary disease. Circulation 112:2627-2633 (Pubitemid 41532599)
4. Dhingra R, Sullivan LM, Fox CS, Wang TJ, D'Agostino Sr RB, Gaziano JM, Vasan RS 2007 Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community. Arch Intern Med 167:879-885 (Pubitemid 46762749)
5. Foley RN, Collins AJ, Ishani A, Kalra PA 2008 Calcium-phosphate levels and cardiovascular disease in community-dwelling adults: the Atherosclerosis Risk in Communities (ARIC) Study. Am Heart J 156:556-563
6. Kestenbaum B, Sampson JN, Rudser KD, Patterson DJ, Seliger SL, Young B, Sherrard DJ, Andress DL 2005 Serum phosphate levels and mortality risk among people with chronic kidney disease. J Am Soc Nephrol 16:520-528 (Pubitemid 41725150)
7. Dobnig H, Pilz S, Scharnagl H, Renner W, Seelhorst U, Wellnitz B, Kinkeldei J, Boehm BO, Weihrauch G, Maerz W 2008 Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality. Arch Intern Med 168:1340-1349 (Pubitemid 351930842)
8. Melamed ML, Michos ED, Post W, Astor B 2008 25-Hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med 168:1629-1637
9. Dietary supplement fact sheet: vitamin D. National Institutes of Health Office of Dietary Supplements. Available at: http://ods.od.nih.gov/factsheets/ vitamind.asp. (accessed January 2011)
10. Surawicz B 1967 Relationship between electrocardiogram and electrolytes. Am Heart J 73:814-834
11. Eryol NK, Colak R, Ozdoǧru I, Tanriverdi F, Unal S, Topsakal R, Katlandur H, Bayram F 2003 Effects of calcium treatment on QT interval and QT dispersion in hypocalcemia. Am J Cardiol 91:750-752 (Pubitemid 36287477)
12. Saikawa T, Tsumabuki S, Nakagawa M, Takakura T, Tamura M, Maeda T, Ito S, Ito M 1988 QT intervals as an index of high serum calcium in hypercalcemia. Clin Cardiol 11:75-78 (Pubitemid 18064959)
13. 1994 Plan and operation of the Third National Health and Nutrition Examination Survey, 1988-94. Series 1: programs and collection procedures. Vital Health Stat 1:1-407
14. 1989 ARIC Investigators: the Atherosclerosis Risk In Communities (ARIC) Study: design and objectives. Am J Epidemiol 129:687-702
15. Drugs that prolong the QT interval and/or induce torsades de pointes ventricular arrhythmia. Available at: http://www.azcert.org/medicalpros/drug- lists/drug-lists.cfm (accessed September 2009)
16. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D 1999 A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130:461-470 (Pubitemid 29135798)
17. Levey AS, Coresh J, Greene T, Stevens LA, Zhang YL, Hendriksen S, Kusek JW, Van Lente F 2006 Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 145:247-254 (Pubitemid 46768608)
18. NCHS note for correction of serum creatinine for NHANES III, NHANES, 1999-2000, 2001-2002, and 2003-2004. Available at: http://www.cdc.gov/nchs/data/ nhanes/nhanes-03-04/general-%20note-for-serum-creatinine.pdf (accessed April 2010)
19. 1996 National Center for Health Statistics, Third National Health and Nutrition Examination Survey, 1988-1994. Reference manuals and reports (CD-ROM). Hyattsville, MD: National Center for Health Statistics
20. Papp AC, Hatzakis H, Bracey A, Wu KK 1989 ARIC hemostasis study-I. Development of a blood collection and processing system suitable for multicenter hemostatic studies. Thromb Haemost 61:15-19
21. 1987 National Heart, Lung, and Blood Institute, Atherosclerosis Risk in Communities (ARIC) Study. Operation manual no. 9: hemostasis determinations. Version 1.0. Chapel Hill, NC: ARIC Coordinating Center, School of Public Health, University of North Carolina
22. Björkman MP, Sorva AJ, Tilvis RS 2009 Calculated serum calcium is an insufficient surrogate for measured ionized calcium. Arch Gerontol Geriatr 49:348-350
23. Rautaharju PM, MacInnis PJ, Warren JW, Wolf HK, Rykers PM, Calhoun HP 1990 Methodology of ECG interpretation in the Dalhousie program; NOVACODE ECG classification procedures for clinical trials and population health surveys. Methods Inf Med 29:362-374
24. Rautaharju PM, Park LP, Chaitman BR, Rautaharju F, Zhang ZM 1998 The Novacode criteria for classification of ECG abnormalities and their clinically significant progression and regression. J Electrocardiol 31:157-187 (Pubitemid 28524275)
25. Bazett HC 1920 An analysis of time relations of electrocardiograms. Heart 7:353-367
26. Peacock M 2010 Calcium metabolism in health and disease. Clin J Am Soc Nephrol 5(Suppl 1):S23-S30
27. Taylor JG, Bushinsky DA 2009 Calcium and phosphorus homeostasis. Blood Purif 27:387-394
28. Eckert R, Chad JE 1984 Inactivation of Ca channels. Prog Biophys Mol Biol 44:215-267
29. Cunha DF, Cunha SF, Ferreira TP, Sawan ZT, Rodrigues LS, Prata SP, Silva-Vergara ML 2001 Prolonged QTc intervals on the electrocardiograms of hospitalized malnourished adults. Nutrition 17:370-372 (Pubitemid 32455539)
30. Narang R, Ridout D, Nonis C, Kooner JS 1997 Serum calcium, phosphorus and albumin levels in relation to the angiographic severity of coronary artery disease. Int J Cardiol 60:73-79 (Pubitemid 27288259)
31. Benoit SR, Mendelsohn AB, Nourjah P, Staffa JA, Graham DJ 2005 Risk factors for prolonged QTc among US adults: Third National Health and Nutrition Examination Survey. Eur J Cardiovasc Prev Rehabil 12:363-368 (Pubitemid 41192168)
32. Amann K, Törnig J, Kugel B, Gross ML, Tyralla K, El-Shakmak A, Szabo A, Ritz E 2003 Hyperphosphatemia aggravates cardiac fibrosis and microvascular disease in experimental uremia. Kidney Int 63:1296-1301 (Pubitemid 36349995)
33. Neves KR, Graciolli FG, dos Reis LM, Pasqualucci CA, Moysés RM, Jorgetti V 2004 Adverse effects of hyperphosphatemia on myocardial hypertrophy, renal function, and bone in rats with renal failure. Kidney Int 66:2237-2244
34. Porthan K, Virolainen J, Hiltunen TP, Viitasalo M, Väänä nen H, Dabek J, Hannila-Handelberg T, Toivonen L, Nieminen MS, Kontula K, Oikarinen L 2007 Relationship of electrocardiographic repolarization measures to echocardiographic left ventricular mass in men with hypertension. J Hypertens 25:1951-1957 (Pubitemid 47356637)
35. Salles G, Leocádio S, Bloch K, Nogueira AR, Muxfeldt E 2005 Combined QT interval and voltage criteria improve left ventricular hypertrophy detection in resistant hypertension. Hypertension 46:1207-1212
36. Almaden Y, Hernandez A, Torregrosa V, Canalejo A, Sabate L, Fernandez Cruz L, Campistol JM, Torres A, Rodriguez M 1998 High phosphate level directly stimulates parathyroid hormone secretion and synthesis by human parathyroid tissue in vitro. J Am Soc Nephrol 9:1845-1852 (Pubitemid 28443481)
37. Pitts TO, Piraino BH, Mitro R, Chen TC, Segre GV, Greenberg A, Puschett JB 1988 Hyperparathyroidism and 1,25-dihydroxyvitamin D deficiency in mild, moderate, and severe renal failure. J Clin Endocrinol Metab 67:876-881
38. Slatopolsky E, Finch J, Denda M, Ritter C, Zhong M, Dusso A, MacDonald PN, Brown AJ 1996 Phosphorus restriction prevents parathyroid gland growth. High phosphorus directly stimulates PTH secretion in vitro. J Clin Invest 97:2534-2540
39. Kristal-Boneh E, Froom P, Harari G, Ribak J 1997 Association of calcitriol and blood pressure in normotensive men. Hypertension 30:1289-1294 (Pubitemid 27476193)
40. Saleh FN, Schirmer H, Sundsfjord J, Jorde R 2003 Parathyroid hormone and left ventricular hypertrophy. Eur Heart J 24:2054-2060 (Pubitemid 37420453)
41. Wareham NJ, Byrne CD, Carr C, Day NE, Boucher BJ, Hales CN 1997 Glucose intolerance is associated with altered calcium homeostasis: a possible link between increased serum calcium concentration and cardiovascular disease mortality. Metabolism 46:1171-1177 (Pubitemid 27418507)
42. Onufrak SJ, Bellasi A, Shaw LJ, Herzog CA, Cardarelli F, Wilson PW, Vaccarino V, Raggi P 2008 Phosphorus levels are associated with subclinical atherosclerosis in the general population. Atherosclerosis 199:424-431